A5033095462- Smoking Behavior and Cessation
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Electronic Health Records Systems
- Air Quality and Health Impacts
- Nicotinic Acetylcholine Receptors Study
- Respiratory and Cough-Related Research
- Augmented Reality Applications
- Asthma and respiratory diseases
- Financial Reporting and Valuation Research
- Computational Physics and Python Applications
- Machine Learning in Healthcare
- Obesity, Physical Activity, Diet
- Inhalation and Respiratory Drug Delivery
- Library Science and Administration
- Integrated Energy Systems Optimization
- Cannabis and Cannabinoid Research
- Building Energy and Comfort Optimization
- Clinical practice guidelines implementation
- Scientific Computing and Data Management
- European and International Law Studies
- Artificial Intelligence in Healthcare
- Pediatric health and respiratory diseases
- Complex Systems and Decision Making
- Consumer Attitudes and Food Labeling
Helsingborgs lasarett
2018-2024
Pfizer (United Kingdom)
2006
Klinik Hirslanden
2005
University Children's Hospital Tübingen
2005
Pfizer (Sweden)
2005
Polyclinic Medical University
2002
University Hospital of Basel
2002
Karolinska University Hospital
1969-1999
ABSTRACT Aim To test the effect of nicotine gum and placebo in smokers not motivated or able to quit smoking with regard reduction cessation. Design This randomized study evaluated versus for up 1 year 411 healthy highly reduce cigarette use. Smoking was defined as self‐reported daily less than 50% baseline any decrease (1 p.p.m. more) carbon monoxide. Setting Pulmonary department, Copenhagen, Denmark. Findings The overall success rate sustained significantly higher at all time‐points active...
Background Smoking reduction may provide a harm-reduction alternative treatment for smokers who are not ready to quit smoking. This study evaluated the efficacy of nicotine gum in helping reduce or Methods randomized, double-blind, placebo-controlled trial involved 364 were but willing their smoking intensity. Participants received either 4-mg (n = 184) placebo 180) as desired up 12 months. The primary outcome was sustained reduction, which defined decrease daily cigarette consumption at...
We have recently published efficacy and safety data of a study using an oral nicotine inhaler in smoking reduction. The current analysis was undertaken to assess the secondary objectives trial: influence long-term reduction on health risk markers. Four hundred healthy volunteers, unable or unwilling stop immediately, were enrolled double-blind, randomized, placebo-controlled trial reduction; 310 evaluable up 2 years. Participants randomized active placebo inhalers as needed for 18 months,...
Journal Article Efficacy of the Nicotine Inhaler in Smoking Reduction: A Double-Blind, Randomized Trial Get access Stephen I. Rennard, M.D., M.D. University Nebraska Medical CenterOmaha, NE Correspondence: Dr. Department Pulmonary & Critical Care Medicine, Center, 985125 Omaha, 68198-5125, USA. Tel: +1 (402) 559-7313; Fax: 559-4878; E-mail: srennard@mail.unmc.edu Search for other works by this author on: Oxford Academic PubMed Google Scholar Elbert D. Glover, Ph.D., Ph.D. West Virginia...
A system for medical information has been developed. The is a general and flexible one which without reprogramming or new programs can accept any alphabetic and/or numeric information. Coded concepts natural language be read, stored, decoded written out. Medical records parts of (diagnosis, operations, therapy, laboratory tests, symptoms etc.) retrieved selected. process simple statistics but even make linear pattern recognition analysis. described used in-patients, outpatients individuals...
Nicotine replacement therapy (NRT) has been demonstrated to be an effective pharmacological treatment for smoking cessation, and most types of NRT have approved as over-the-counter (OTC) medications. In effort create a fast-acting, flexible, discreet NRT, nicotine mouth spray (NMS) developed. This study was designed assess the efficacy safety NMS in naturalistic setting United States.This multicenter, randomized, double-blind, placebo-controlled, parallel-group, 26-week 1198 smokers...
Abstract Aims To determine whether nicotine mouth spray provides rapid and prolonged relief of urges to vape measure the steady‐state plasma levels during vaping ad libitum usage in e‐cigarette users. Design Randomized, parallel group, double‐blind trial. Setting Single site at Hammersmith Medicines Research Ltd (HMR), London, UK. Participants 216 (25.9% females, average age 27.6 ± 7.63 [standard deviation, SD]) exclusive vapers who used their within 30 minutes waking up had vaped about 2...